- Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug CNBC
- FDA adviser resigns over approval of new Alzheimer’s drug CNN
- New Alzheimer’s Drug Gives Some Hope of Eventual Cure | NBCLA NBCLA
- A new Alzheimer’s drug may just be false hope. Will our patients pay the price? The Washington Post
- America’s approval of an Alzheimer’s drug is premature The Economist
- View Full Coverage on Google News
Source: Weather